ABVC BioPharma
(NASDAQ:ABVC)
$1.23
0[0.00%]
Last update: 6:42PM Get Real Time Here

GET A REPORT ON ABVC SENT RIGHT TO YOUR INBOX

ABVC BioPharma Stock (NASDAQ:ABVC), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.
Consensus Rating1
Hold
Highest Price Target1
$0.00
Lowest Price Target1
$0.00
Consensus Price Target1
$0.00

Analyst Rating Summary1

Analyst Ratings
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Maxim Group

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for ABVC BioPharma

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
11/16/2022ABVCBuy Now
ABVC BioPharma
$1.23Maxim Group
Jason McCarthy
DowngradeBuy → HoldGet Alert

FAQ

Q

What is the target price for ABVC BioPharma (ABVC)?

A

The latest price target for ABVC BioPharma (NASDAQ: ABVC) was reported by Maxim Group on November 16, 2022. The analyst firm set a price target for $0.00 expecting ABVC to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for ABVC BioPharma (ABVC)?

A

The latest analyst rating for ABVC BioPharma (NASDAQ: ABVC) was provided by Maxim Group, and ABVC BioPharma downgraded their hold rating.

Q

When is the next analyst rating going to be posted or updated for ABVC BioPharma (ABVC)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ABVC BioPharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ABVC BioPharma was filed on November 16, 2022 so you should expect the next rating to be made available sometime around November 16, 2023.

Q

Is the Analyst Rating ABVC BioPharma (ABVC) correct?

A

While ratings are subjective and will change, the latest ABVC BioPharma (ABVC) rating was a downgraded with a price target of $0.00 to $0.00. The current price ABVC BioPharma (ABVC) is trading at is $1.23, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch